Form 4 Tracker
Kate Haviland

Director · 1 filing · Latest: Apr 29, 2026

Avalyn Pharma Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KATHRYN D HAVILANDApr 1, 2025
Proposed Sale
$88.512,498$221.1K
KATHRYN D HAVILANDNov 29, 2024
Proposed Sale
$95.103,799$361.3K